FDA Updates Highlighting the Latest Cancer Treatments : Oncology Times
An abstract is unavailable.
Related Articles
Dr Gerds on Efficacy Data Supporting the Use of Momelotinib in Myelofibrosis With Anemia
Aaron Gerds, MD, discusses data from the SIMPLIFY-1 and MOMENTUM trials which support the use of momelotinib in myelofibrosis with anemia.
Elacestrant Shows Tolerability in Combination With CDK4/6, PI3K Inhibitors in Advanced ER+ Breast Cancer
Elacestrant was partnered with multiple targeted agents across varying dose levels and schedules for patients with estrogen receptor–positive advanced breast cancer.
Turning grief into purpose
Full of stamina and determination, Lynn Lippert supported others and did what she loved through 24 years of living with metastatic breast cancer. Lippert’s life…
Healing Visual Arts Program Offers New Strategy for Artwork at Fox Chase Cancer Center and Network Locations
Art remains a vital part of Fox Chase Cancer Center’s culture. From the symbolic sculpture, The Diamond, greeting visitors outside the main entrance to the…
An Overview of Current Methods for Real-world Applications… : Epidemiology
rial findings to target populations. When the trial sample and target populations are distinct, transportability methods may be applied for this purpose. However, generalizability and…
An Overview of the Treatment Landscape for Anemia Management in LR-MDS
Thomas W. LeBlanc, MD, MA, discusses how the standard of care (SOC) options for anemia management in patients with low-risk myelodysplastic syndromes (LR-MDS) typically involve…
Autologous HCT Does Not Provide Added Survival Benefit in Patients With MCL in First CR
Results of the EA4151/BMT-CTN 1601 trial showed similar progression-free and overall outcomes with the addition of autologous transplant to rituximab in mantle cell lymphoma.
What is the Whipple procedure? Explaining Randy Moss’ cancer surgery
Pancreatic cancer survival rates have more than doubled in the past decade. It’s not because of a single breakthrough, but better knowledge of the cancer,…
Axi-Cel Sustains Long-Term Efficacy in R/R Follicular Lymphoma and MZL
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.